Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 20, 2021 (5 years ago)

Quebracho 4C

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Out-of-specification test results obtained for identification testing based on HPTLC analysis.

Cause type: Failed specification

A physical or chemical test other than potency, dissolution, impurity or stability failed - pH, viscosity, appearance, tablet integrity, fill volume. A product outside its own specification may not perform as designed, even if the active ingredient is present. All failed specification recalls.

What was recalled

Quebracho 4C, 5C, 6C, 12C, 30C, Fever*, Sucrose/Lactose Pills, 5C Packaged as a) 4dr; 6C Packaged as b) 4 Dram UPC 7 40640 44092 6; c) 2 oz UPC 7 40640 44100 8; 12C Packaged as d) 4 Dram; e) 2 oz; 30C Packaged as f) 2 dr UPC 7 40640 44090 2; g) 4 Dram, UPC 7 40640 44094 0; h) 1 oz, UPC 7 40640 44098 8; i) 2 oz, UPC 7 40640 44102 2; WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.

Recalling firm
Washington Homeopathic Products, Inc.
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0867-2021 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Washington Homeopathic Products, Inc.

All 2021 recalls
Class III · Low risk

Complete 30C/200C Homeopathic Kit

Labeling: Label Mix-up: Some bottles of Ferrum Phosphoricum 200C were incorrectly labeled as Ferrum Metallicum 200C.

Terminated Labeling / mix-up Washington Homeopathic Products, Inc. D-0618-2024
Class II · Moderate risk

Vaccinotoxinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1141-2022
Class II · Moderate risk

Tuberculinum

cGMP deviations

Terminated cGMP deviation Washington Homeopathic Products, Inc. D-1139-2022

Other failed specification recalls from 2021

All failed specification recalls
Class II · Moderate risk

Pregabalin Capsules

Failed Tablet/Capsule Specifications: Out of Specification results for particle Size Distribution and Bulk Density of the Active Pharmaceutical Ingredient.

Terminated Failed specification Sun Pharmaceutical Industries INC NDC 47335-687-88 D-0361-2022